CANI Gains IRS Non-Profit Status

(CLOVIS, CA) - The Consultants Association for the Natural Products Industry (CANI) has announced it has received approval from the Internal Revenue Service as an official non-profit 501 (c) (6) organization, according to Karen A. Weaver, partner in the Chicago-based law firm of Weaver & Amin, working with natural products industry companies and organizations.

Set to embark on its 12th year, the organization consists of national and international member firms from the U.S., Canada and Australia. CANI was founded in 1991 by consultants committed to enhancing the growth and integrity of the industry by promoting the education and improvement of manufacturing, distribution, advertising and ethical standards that help the industry provide safe and beneficial products to the general public. CANI members strive to achieve its high standards by ensuring that quality ingredients are used in products; providing distributors, retailers and consumers with educational information about products and their ingredients; requiring truthful dissemination regarding the efficacy of compliance with all regulatory guidelines; and establishing uniform guidelines on research and development as well as for the marketing and advertising of products in various and relevant industries.

“This is a giant step forward for the organization,” says Karena K. Dillon, CANI president. “We’ve expanded our scope in recent years and this status puts the cap on a record growth year for CANI and its members. Non-profit status allows the organization to take a larger leadership role in helping the industry to grow and enlighten consumers about alterative health modalities.”

Association members currently provide expertise in a wide-range of areas including marketing, advertising, public relations and publicity, business strategy, promotional events, Internet marketing, publishing, industry analysis, legal, trademark, regulatory affairs, organizational development, product development, scientific substantiation, insurance, package design, video production, training and education, risk management, sourcing, sales management, executive recruiting, government regulations, food service, research and development, store design, translation, and web site design.

According to Dillon, the organization has recently provided several companies seeking help with product manufacturing and labeling, corporate publicity and identity, product introduction to the United States, legal counsel, broker/distributor management, organic product development, insurance and FDA regulatory assistance.

For more information regarding consultant referral or membership,
call CANI at (559) 325-7192 or visit the web site at www.cani-consultants.com. The email address is info@cani-consultants.com.

Danisco and Direvo Sign Enzyme Development Collaboration

COLOGNE, Germany, and COPENHAGEN, Denmark, Nov. 26 /PRNewswire/ -- Direvo Biotech AG and Danisco A/S today announced the signing of a collaboration agreement under which both parties will develop an industrial enzyme.

Under the terms of the agreement, Danisco will obtain worldwide exclusive rights to commercialize the products developed under this collaboration. In return, Direvo will receive research and development funding, milestone payments and royalties on future product sales.

"Direvo is very delighted by this promising relationship with Danisco, one of the world's largest producers of food and feed ingredients," commented Dr. Andre Koltermann, President and Chief Executive Officer of Direvo. "This agreement represents our second collaboration with a strong partner and strongly validates our business concept of creating high value with leading companies."

"We are impressed with Direvo and we are excited to see how the technology can help our ingredient development efforts," says Dr. Leif Kjaergaard, Senior Vice President, Global Innovation and Business Development, Danisco A/S.

About Direvo

Direvo Biotech AG based in Cologne, Germany, is a leading company in screening-based directed evolution and applies its integrated proprietary technologies to the development of better biopharmaceuticals and improved industrial enzymes. With its rapid and highly flexible screening-based directed evolution process, Direvo is focused on several multi-billion dollar markets. The company has collaborations with Danisco, Novozymes and Evotec OAI and a pipeline of numerous potential products including protein pharmaceuticals, industrial enzymes, chemical biocatalysts and enzymes for food and feed. For further company information, log onto Direvo's Web site on the Internet at www.direvo.com.

About Danisco

Danisco develops and produces functional ingredients, sweeteners and sugar. The group employs 8,000 people in 38 countries and reported net sales of DKK 17.7 billion in 2001/02. Danisco's broad product portfolio includes emulsifiers, enzymes, starter cultures, stabilizers, flavors and sweeteners such as xylitol and fructose. A large part of the ingredients are produced from natural raw materials and contributes, for instance, to improving the texture of products such as bread, ice cream, yogurt and other products. Danisco is also one of the largest and most efficient sugar producers in Europe. For further company information, log onto Danisco's Web site on the Internet at www.danisco.com.


Contacts:

DIREVO Biotech AG Danisco A/S
Christine Kasper Carsten Sivertsen
Public Relations Media Relations Manager
Phone: +49 221 8887 160 Phone: +45 3266 2049
Fax: +49 221 8887 111 Mobile : + 45 2145 2034
E-Mail: kasper@direvo.com E-Mail: sfcsi@danisco.com

Source: Direvo Biotech AG

CONTACT: Christine Kasper, Public Relations of Direvo Biotech AG,
+49-221-8887-160, fax, +49-221-8887-111, or kasper@direvo.com; or Carsten
Sivertsen, Media Relations Manager of Danisco A-S, +45-3266-2049, Mobile,
+45-2145-2034, or sfcsi@danisco.com


Web Site: http://www.direvo.com/
http://www.danisco.com/

To see more releases from Direvo Biotech AG, Click Here

This company's web site http://www.direvo.com

ZonePerfect Nutrition Company Reports Highest One Month Sales in Company History

Company Named to Inc 500 List of Fastest Growing Private Companies

BOSTON, Nov. 25 /PRNewswire/ -- ZonePerfect Nutrition Company, the company that offers great tasting, healthy, nutritious products for busy people, today announced the highest one-month sales revenues in the company's history.

ZonePerfect Nutrition reported October 2002 sales revenues of $8.5 million, a 110 percent increase over last October's revenues of $3.2 million.

The company also reported higher revenues for the first quarter of fiscal year 2003 ending September 30. The company announced $21.2 million in revenues for the quarter, a 133 percent increase from the first fiscal quarter of 2002 when revenues were $9.1 million.

The ZonePerfect Nutrition Company manufactures and distributes popular food and supplement products that follow the 40/30/30 ratio of carbohydrate, protein, and dietary fat.

"ZonePerfect sales have increased in part due to additional shelf space at food, drug and mass outlets around the country, making it the number one brand at many of these retailers," says Christopher Baker, chief executive officer of ZonePerfect Nutrition Company. "We look forward to additional growth as more consumers switch to a healthier lifestyle and use ZonePerfect products as tools to help achieve their goals."

In addition to the popularity of its prepared foods, shakes and snacks, the ZonePerfect Nutrition bar is the 5th ranked branded vendor in the snack/granola bar category and the company recently introduced five new nutrition bar flavors. ZonePerfect has sold more than 172 million bars.

As a result of its tremendous growth, ZonePerfect made its debut at number 307 on Inc Magazine 500 list of fastest growing private companies.

"This is the first Inc 500 ranking to reflect the full impact of the recession," said Inc Editor John Koten. "Yet these entrepreneurs are managing to confound the naysayers and move ahead despite the obstacles. They're showing that the smart strategies can succeed even in the toughest of times."

Despite a current slowdown in the economy, ZonePerfect's management forecasts that sales will grow at a 40% compounded rate for the next five years.

The ZonePerfect Nutrition Program is a science-based nutrition program designed to provide great-tasting, healthy, and nutritious products to help people quickly achieve and maintain their health and fitness goals by establishing a hormonally controlled "Zone" 24 hours a day. This zone is a metabolic state of optimal health with the potential to affect energy levels, physical performance, and weight-loss.

ZonePerfect Nutrition Bars and other ZonePerfect products are available online at www.zoneperfect.com and at retail locations throughout the country.

About ZonePerfect Nutrition Company

ZonePerfect Nutrition Company produces great tasting, healthy, and nutritious products for time-starved people. Through years of science-based research, the company has developed an incredible line of nutritious food products for people who want to eat healthily but just can't find the time and refuse to sacrifice great taste. All ZonePerfect Nutrition Company products contain the same 40/30/30 ratio of carbohydrate, protein, and dietary fat, and are convenient, easy to store, and quick to prepare. The ZonePerfect Nutrition Company recently won the 2002 Retail Excellence (REX) Best of the Year Award for Health Niche Marketing by the nation's drug chain retailers. Consumers looking to find additional information on the ZonePerfect Nutritional Program or wishing to purchase products can do so by visiting www.zoneperfect.com .

OrderDog And Tree of Life Plan Donation To Support Industry

Portion of New Membership Fees Will Be Donated to NNFA

LEWISVILLE, TX, --In a joint effort to further support the natural products industry, OrderDog ® ,Inc., and Tree of Life, Inc., will donate $25 to the NNFA (National Nutritional Foods Association) for each new retailer that signs up for the OrderDog system during November 15, 2002 ­ March 15, 2003.

OrderDog, Inc., a technology services company that provides secure Web-based third party business-to-business solutions to the natural products industry, has developed a strategic marketing relationship with Tree of Life, Inc., a leading marketer and distributor of natural and specialty foods, designed to educate industry members about the OrderDog system.

"Leaders work with leaders and we chose the NNFA as the beneficiary of this program because we knew the funds would go to help retailers become more successful at what they do, which is what OrderDog is all about," stated Darrin Peterson, president of OrderDog, Inc. "We are always looking for ways to better our industry and firmly believe that NNFA has the leadership and vision to take industry members to the next level. We are proud to support their efforts."

OrderDog will present a check to NNFA at its upcoming industry trade show, NNFA MarketPlace, June 27-29, 2003, in Las Vegas, NV.

"This effort by OrderDog and Tree of Life is a 'win-win' situation for everyone involved," said David Seckman, NNFA¹s executive director and CEO. ³Now, when a retailer decides to use the OrderDog system, it's not only a decision to enhance their business, but one that supports the industry, as well."

For more information on OrderDog, Inc. contact Tiia Sumera at press@orderdog.com. For more information on the NNFA contact Tracy Taylor at ttaylor@nnfa.org.


About OrderDog, Inc.

The OrderDog.com online service directly connects retailers with manufacturers and distributors around the clock allowing them to electronically catalog and purchase product, streamlining the entire ordering process. The OrderDog system permits the end user to easily monitor and track order status, avoid inventory out-of-stocks and receive updated email notifications while providing access to a real time customer support center.

Headquartered in Lewisville, Texas, OrderDog, Inc., is built with the most reputable hardware and software from leading industry partners including AOL, Cisco, Dell, Gateway, Microsoft and Xodiax. For more information and online demonstrations of OrderDog, visit http:// www.OrderDog.com or call 1-866-ORDERDOG (1-866-673-3736).


About Tree of Life, Inc.

Tree of Life, Inc., is a wholly owned subsidiary of Wessanen U.S.A., Inc., a subsidiary of Koninklijke Wessanen, the Netherlands. The U.S. headquarters are located in St. Augustine, Florida. Wessanen has over two centuries of experience in the food industry. Tree of Life serves customers throughout the United States and Canada. For further information visit www.treeoflife.com or call 1-800-260-2424.


About NNFA

Headquartered in Newport Beach, Calif., the National Nutritional Foods Association is the nation¹s largest and oldest non-profit organization dedicated to the natural products industry. NNFA represents nearly 5,000 retailers, manufacturers, wholesalers and distributors of natural products, including foods, dietary supplements, and health/beauty aids. For further information visit www.nnfa.org or call 1-800-966-6632.

# # #

Soy is Among 'Most Promising' Remedies for Women Suffering From Menopausal Discomfort, Report Says

WASHINGTON, Nov. 25 /PRNewswire/ -- More recommendations for intake of soyfoods by women are being made by health specialists in the wake of recent findings from the Women's Health Initiative warning against hormone replacement therapy (HRT).

The Johns Hopkins medical letter, Health After 50, has addressed "easing through menopause without HRT" in depth in its November edition.

Soy appears to be one of the most promising remedies to overcome menopausal discomfort, the publication reported. Citing a report issued by the American College of Obstetricians and Gynecologists (ACOG), the Johns Hopkins medical letter pointed out that dietary soy "is a staple in Asia" and has been proposed as "one reason for the lower rate of perimenopausal symptoms reported by Asian women."

Soyfoods "contain isoflavones, substances that have weak estrogen-like effects," the publication said.

"According to a report issued by the American College of Obstetricians and Gynecologists," it said, "soy appears to be among the most promising of these remedies." The recommendation of soy was based on dietary intake.

Meanwhile, a survey conducted by the North American Menopause Society has found that 30 percent of the survey's respondents said they have used herbs or supplements to overcome perimenopausal discomfort.

In addition to soy, other plant-based products found somewhat promising for relieving mild to moderate discomfort were black cohosh, a member of the buttercup family, and St. John's wort, a shrubby perennial with yellow flowers, the Johns Hopkins medical letter said.

Martek's DHA Improves Arterial Flexibility in Overweight Children

Data Presented at Annual Scientific Sessions of American Heart Association

COLUMBIA, Md., Nov. 22 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (NASDAQ: MATK) today announced the results of a clinical investigation examining the effects of docosahexaenoic acid (DHA) on endothelial function in children with elevated blood lipid levels (hyperlipidemia). Hyperlipidemia in children is a risk factor for early coronary heart disease. Clinical data demonstrated that when patients supplemented a specialized diet with DHA, they showed improved endothelial function as compared to the specialized diet alone. Complete study findings were presented on November 18 at the 2002 Scientific Sessions of the American Heart Association.

The double-blind, placebo-controlled, randomized crossover trial, which enrolled over 14 overweight subjects between the ages of 10 and 19, measured improved endothelial function by changes in the patients' endothelium- dependent flow mediated dilation (FMD). Researchers found that, when patients received DHA, they experienced significant improvements in their arterial flow, indicating that their arteries had become more flexible.

"The exciting news here is that supplementation with DHA increased blood vessel dilation, an important indicator of cardiovascular health," said lead investigator Marguerite Engler, Ph.D., RN, MS, FAHA, University of California, San Francisco. "By adding DHA to their specialized diets, we were able to improve the children's cardiovascular health."

"It's great to see clinical studies that are now pinpointing the cardiovascular benefits of DHA," stated Henry Linsert, Jr., Martek Chairman and CEO.

The DHA used in this study was Martek's vegetarian, contaminant-free form of the omega-3 fatty acid. Early this week, the American Heart Association published a scientific statement outlining the findings of a comprehensive report that examined the cardiovascular health benefit of omega-3 fatty acids such as DHA. The report concluded that healthy people should eat omega-3 fatty acids from fish and plant sources to protect their hearts.

Martek Biosciences Corporation develops, manufactures and sells products from microalgae. The Company's products include: (1) specialty, nutritional oils for infant formula that aid in the development of the eyes and central nervous system in newborns; (2) nutritional supplements and food ingredients that may play a beneficial role in promoting mental and cardiovascular health throughout life; and (3) new, powerful fluorescent markers for diagnostics, rapid miniaturized screening, and gene and protein detection.

This press release contains forward-looking statements regarding Martek's products. Such statements involve risks and uncertainties that could cause future actual results to differ due to a variety of risk factors, including without limitation those factors set forth in Martek's filings with the Securities and Exchange Commission.

CONTACT: Angela Tsetsis, Director of Marketing, of Martek Biosciences Corporation, +1-410-740-008.

Complementary and Alternative Therapies Now Being Evaluated In Controlled Scientific Studies as Nearly Half of U.S. Adults Go Outside the Traditional Health System

NEW YORK, Nov. 24 /PRNewswire/ -- Although nearly half of U.S. adults are
going outside the health system for at least some of their care and spending
about $30 billion a year for the privilege, few complementary and alternative
therapies have been evaluated in controlled scientific studies-until now. At
research hospitals around the country, physicians are studying herbs and
biofeedback as rigorously as they would a new antibiotic, Newsweek reports in
the Dec. 2 cover story (on newsstands Monday, Nov. 25).
(Photo: http://www.newscom.com/cgi-bin/prnh/20021124/NYSU006 )
Complementary and alternative medicine, or CAM, is not a single, unified
tradition. The term covers practices ranging from the credible (acupuncture,
chiropractic) to the laughable (coffee enemas), writes Senior Editor Geoffrey
Cowley. Because few of these therapies have been thoroughly evaluated in
controlled studies, their effectiveness is still widely debated. But now no
one disputes their significance. After dismissing CAM therapies as quackery
for the better part of a century, the medical establishment now finds itself
racing to evaluate them. The short-term goal is to identify the most
effective and safe alternative therapies and make them part of routine
clinical practice. But the larger mission is to spawn a new kind of
integrative medicine, one that employs the rigor of modern science without
being constrained by it.
Studies are now underway to determine whether acupuncture can ease
arthritis pain, whether vitamin E and selenium help prevent prostate cancer
and whether ginkgo biloba can preserve mental function in the elderly. And
while these huge clinical trials plod along, researchers are also using state-
of-the-art laboratory techniques to glimpse the physiological effects of
different CAM remedies. By placing CAM under the microscope, scientists will
no doubt gain a better sense of which therapies work, how they work, whether
they're safe and who is most likely to benefit, writes Cowley.
Newsweek's cover story also looks at the effectiveness of Chinese
medicine. Modern science is starting to verify that some of the age-old
remedies really work and the evidence is promising enough that Western
researchers have begun looking to China for potential new therapies, writes
Reporter Anne Underwood. CAM therapies are also playing a bigger role in
pediatric medicine. Senior Writer David Noonan reports that there now is a
small but growing cadre of researchers who are subjecting pediatric CAM
therapies to the rigors of traditional, randomized, controlled clinical trials
to find out what will work best for kids. And in the psychiatric field,
Americans are avidly pursuing alternative treatments since the effectiveness
of traditional drugs vary widely from person to person and often come with an
array of side effects. While the research on these therapies is still
preliminary, the science is beginning to improve, reports General Editor
Claudia Kalb.

(Read Newsweek's news releases
at http://www.Newsweek.MSNBC.com

Surprising Results From New Vitamin E Oxidative Stress Isoprostane Dose Response Study Featured In Presentations at American Heart Association and Oxygen Society Conferences

November 20, 2002: Researchers at Vanderbilt University presented the results of a vitamin E dose response and time course study on oxidative stress at this weeks American Heart Association and Oxygen Society meetings. The American Heart Association meeting is being held in Chicago and the Oxygen Society meeting is being held in San Antonio. The results are being delivered in oral presentations at both conferences by L. Jackson Roberts M.D. and Jason Morrow M.D. from the Department of Clinical Pharmacology at Vanderbilt University Medical School, and published in the proceedings.

The study measured the effects of increasing doses of vitamin E as alpha tocopherol on a patented biomarker for measuring oxidative stress in-vivo called isoprostanes (F2 IsoPs). Isoprostanes are produced in-vivo by oxidation of lipids, and can be measured in blood or non-invasively urine. The isoprostanes have become the gold standard for the in-vivo measurement of free radicals in the body, and over 250 papers per year are being published which use the isoprostanes as an index for measuring oxidative stress in-vivo. The isoprostanes have been correlated with many different diseases including atherosclerosis, diabetes, Alzheimer's disease, environmental pollution, cigarette smoking, homocysteine, alcohol, pesticides, and high blood pressure, in addition to other physiological health issues. For the first time, scientists now have a tool for measuring the effects of oral anti-oxidant supplements and drugs on free radical production in-vivo. Surprisingly, researchers are finding out that anti-oxidants that looked good in-vitro, don't always prove to be effective in-vivo.

The clinical trial involved 35 subjects with elevated cholesterol who were supplemented with either 0, 100, 200, 400, 800, 1600, or 3200 IU/d of alpha tocopherol for 16 weeks. A run in period to establish the time course for the highest dose effect on oxidative stress was conducted in 8 subjects at a dose of 3200 IU/d for 20 weeks prior to commencement of the dose response phase of the study. The time course study indicated that the maximum reduction in oxidative stress as measured by the isoprostanes was not achieved until 16 weeks of dosing and levels remained reduced at 20 weeks. No effect was observed on plasma F2 IsoPs (oxidative stress) at a dose of 400 IU/d or less. At a dose of 800 IU/d, plasma F2IsoPs levels were reduced by 30%, at 1600 IU/d levels were reduced by 35%, and at 3200 IU/d reductions of 49% were achieved. This study may provide an answer for why clinical trials of alpha tocopherol in the prevention of atherosclerotic events have largely failed to show a beneficial effect. Implicit in these trials is the assumption that the doses of alpha tocopherol tested effectively inhibit oxidative stress. This study represents one of the first dose finding studies with commonly used anti-oxidants that enables the selection of the appropriate dose of a particular anti-oxidant ingredient or formula.

Lipoprotein Diagnostics, Inc., a development stage diagnostic company has the exclusive rights to commercialize the isoprostanes as biomarkers for the measurement of oxidative stress in-vivo and in foods as an index of food spoilage. The company is developing an easy to use consumer friendly test that can be used to measure the effects of oral anti-oxidant supplementation on the body by measuring this marker in urine with a simple dipstick. Urine represents a non-invasive means of diagnosing whole body oxidative stress, and is preferred by consumers over blood. Future development includes an electronic device with Internet connectivity that will be able to provide consumers and physicians with quantitative results in minutes. "Now consumers, scientists, and physicians will be able to study and determine the optimum doses for anti-oxidant products, as well as test and screen new anti-oxidant ingredients for efficacy" said Eric Kuhrts, President of Lipoprotein Diagnostics, Inc. "This will result in a radical shift in thinking for supplement marketers in the future, as each formulation will be able to be tested in-vivo, and in-vitro/in-vivo correlation's of anti-oxidants will be subjected to scrutiny" stated Kuhrts. An easy, quick test for food spoilage is also in development by the company, and corporate partners are being sought who have an interest in this application.

 

Editorial: The Appetite for Functional Products

By Len Monheit
lenmon@npicenter.com

Fortification or adding functional ingredients to products is a hotly debated issue. A challenging regulatory environment, inability to make certain claims and numerous other challenges including market positioning has left companies wary and unsure about strategy.

Obesity and diabetes are on the rise, health awareness is increasing, there is a trend towards self management (if not outright self diagnosis) of health issues, and it would seem that the functional food category is poised for exponential growth. It would also seem that company resources (ingredients, service companies, regulators and brand manufacturers) would be heavily allocated into this area. We have seen solid category growth, we have seen more emphasis, but the levels observed until now are disproportionate to the opportunities. There is hesitancy for many companies to ‘take the plunge’.

There are several gaps which must be addressed for full potential to be realized:

1. The ‘Nutrition Gap’
This is the gap between what consumers presently consume and what should be consumed for health maintenance.

2. The Translation Gap
This is the gap between science / research and marketing / communications. Part of this is due to limitations in ability to make health claims for foods, but a fundamental communications barrier exists between these groups. There needs to be a platform that effectively translates good and compelling research into substantiated messages in the hands of marketing professionals.

3. The Consumer Capacity Gap.
WeightWatchers has been extremely successful with its points program, simplifying the process for consumers wanting an easy way to know the relative effect of the foods they consume. More recently there has been discussion about Glycemic Index (GI) as a way of assigning relative values to different types of carbohydrate containing products and blood glucose effects. Consumers have also heard sporadic reference to the term ORAC as a measurement of anti-oxidant capacity of certain products. Heightened consumer awareness would be beneficial.

All of these programs attempt to simplify a body of scientific information into presentable and understandable formats. The key is achieving standardization and broad acceptance and then using all channels to build awareness. Several question come to mind:

  • What level of information is the average consumer prepared to handle?’
  • Can this be raised?
  • What forces and resources need to be activated to raise this level?

4. The Consumer Motivation Gap.
Closely related to the capacity gap, this refers to the fact that consumers are aware that diabetes and obesity are on the rise. They realize that there are products, (supplements, natural health products, foods and beverages) that can help. Yet unless there is a personally compelling reason to change, behavior remains constant. And for too large a portion of our population, this compelling reason does not exist.

Many of these gaps are beginning to close, forced by rising health care costs and additional nutritional references and resources available to the medical community and consumers.

Are they closing fast enough to impact health and at the same time allow committed companies to justify their investments?

Congressional Champions, Burton and Hatch to Deliver Keynote at NNFA Marketplace 2003

NEWPORT BEACH, Calif., (November 22, 2002) - Two of the natural products industry's most celebrated congressional champions, Rep. Dan Burton (R-Ind.) and Sen. Orrin Hatch (R- Utah) will deliver the keynote address on June 28 at NNFA MarketPlace 2003, June 27-29 in Las Vegas, Nev.

"We look forward to having two such prominent legislators speak at NNFA MarketPlace," said David R. Seckman, NNFA executive director and CEO. "Both Congressman Burton and Senator Hatch are strong industry champions of industry issues. Having them as our guests at the show will bring their efforts on the Hill closer to home for attendees."

Burton serves as the chairman of the House Committee on Government Reform, one of the most influential and powerful committees in the House. As chair, Burton has held several hearings in Washington focusing on obtaining favorable treatment of dietary supplements and furthering research and understanding of alternative medicine. He has received both the NNFA Lifetime Achievement Award the NNFA Congressional Champion Award.

As the former chairman and now ranking Republican member of the Senate Judiciary Committee, Hatch has had a long-standing history supporting the natural products industry in Congress. Hatch was an author of the Dietary Supplement Health and Education Act (DSHEA) of 1994 and has since continually worked to ensure its full implementation as Congress intended. He has also received both the NNFA Lifetime Achievement Award and the NNFA Congressional Champion Award.

NNFA MarketPlace 2003 is the 66th annual trade show of the National Nutritional Foods Association. The show will take place at the Las Vegas Convention Center June 27 -29. For more information about trade show registration and activities, contact NNFA at (800) 966-6632, ext. 237, e-mail conventions@nnfa.org, or visit NNFA's Web site at www.nnfa.org.

The National Nutritional Foods Association (www.nnfa.org) is the nation's largest and oldest non-profit organization dedicated to the natural products industry. NNFA represents nearly 5,000 retailers, manufacturers, wholesalers and distributors of natural products, including foods, dietary supplements, and health/beauty aids. Headquartered in Newport Beach, Calif., NNFA has seven regional offices throughout the United States and is governed by a 22-member board of directors representing all industry segments.

# # #